By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – French biopharmaceutical firm Transgene today and the Ligue nationale contre le cancer, or the French league against cancer, today announced an agreement to identify membrane-specific targets from gene expression data in order to develop new oncology biotherapies.

The data was collected by Ligue from more than 4,800 tumors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.